Have a personal or library account? Click to login
Gene expression levels of DNA methyltransferase enzymes in Shank3-deficient mouse model of autism during early development Cover

Gene expression levels of DNA methyltransferase enzymes in Shank3-deficient mouse model of autism during early development

Open Access
|Dec 2021

References

  1. Alex AM, Saradalekshmi KR, Shilen N, Suresh PA, Banerjee M. Genetic association of DNMT variants can play a critical role in defining the methylation patterns in autism. IUBMB Life 71, 901–907, 2019.10.1002/iub.2021
  2. Beri S, Tonna N, Menozzi G, Bonaglia MC, Sala C, Giorda R. DNA methylation regulates tissue-specific expression of Shank3. J Neurochem 101, 1380–1391, 2007.10.1111/j.1471-4159.2007.04539.x
  3. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, Silva AJ, Fan G. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 13, 423–430, 2010.10.1038/nn.2514
  4. Garrido N, Cruz F, Egea RR, Simon C, Sadler-Riggleman I, Beck D, Nilsson E, Ben Maamar M, Skinner MK. Sperm DNA methylation epimutation biomarker for paternal offspring autism susceptibility. Clin Epigenetics 13, 6, 2021.10.1186/s13148-020-00995-2
  5. Jobe EM, Zhao X. DNA methylation and adult neurogenesis. Brain Plast 3, 5–26, 2017.10.3233/BPL-160034
  6. Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz-Picciotto I, Hansen RL, Van de Water J, Pessah IN, Jiang R, Robinson WP, LaSalle JM. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res 1, 169–178, 2008.10.1002/aur.24
  7. Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z, Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437–442, 2011.10.1038/nature09965
  8. Reichova A, Bacova Z, Bukatova S, Kokavcova M, Meliskova V, Frimmel K, Ostatnikova D, Bakos J. Abnormal neuronal morphology and altered synaptic proteins are restored by oxytocin in autism-related SHANK3 deficient model. Mol Cell Endocrinol 518, 110924, 2020.10.1016/j.mce.2020.110924
  9. Schenkel LC, Aref-Eshghi E, Rooney K, Kerkhof J, Levy MA, McConkey H, Rogers RC, Phelan K, Sarasua SM, Jain L, Pauly R, Boccuto L, DuPont B, Cappuccio G, Brunetti-Pierri N, Schwartz CE, Sadikovic B. DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome. Clin Epigenetics 13, 2, 2021.10.1186/s13148-020-00990-7
  10. Srancikova A, Bacova Z, Bakos J. The epigenetic regulation of synaptic genes contributes to the etiology of autism. Rev Neurosci 32, 791–802, 2021.10.1515/revneuro-2021-0014
  11. Zhang F, Rein B, Zhong P, Shwani T, Conrow-Graham M, Wang ZJ, Yan Z. Synergistic inhibition of histone modifiers produces therapeutic effects in adult Shank3-deficient mice. Transl Psychiatry 11, 99, 2021.10.1038/s41398-021-01233-w
  12. Zhu L, Wang X, Li XL, Towers A, Cao X, Wang P, Bowman R, Yang H, Goldstein J, Li YJ, Jiang YH. Epigenetic dys-regulation of SHANK3 in brain tissues from individuals with autism spectrum disorders. Hum Mol Genet 23, 1563–1578, 2014.10.1093/hmg/ddt547
  13. Zhu W, Li J, Chen S, Zhang J, Vetrini F, Braxton A, Eng CM, Yang Y, Xia F, Keller KL, Okinaka-Hu L, Lee C, Holder JL Jr, Bi W. Two de novo novel mutations in one SHANK3 allele in a patient with autism and moderate intellectual disability. Am J Med Genet A 176, 973–979, 2018.10.1002/ajmg.a.38622
DOI: https://doi.org/10.2478/enr-2021-0025 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 234 - 237
Published on: Dec 7, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Annamaria Srancikova, Alexandra Reichova, Zuzana Bacova, Jan Bakos, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.